Particle based vaccine formulations for transcutaneous immunization

References

• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992; 1104:226 - 32; http://dx.doi.org/10.1016/0005-2736(92)90154-E; PMID: 1550849
   PubMed Web of Science ®Google Scholar
• Gratieri T, Schaefer UF, Jing L, Gao M, Kostka KH, Lopez RF, et al. Penetration of quantum dot particles through human skin. J Biomed Nanotechnol 2010; 6:586 - 95; http://dx.doi.org/10.1166/jbn.2010.1155; PMID: 21329051
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mishra V, Rawat A, Dubey P, Mahor S, Jain S, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 2005; 293:73 - 82; http://dx.doi.org/10.1016/j.ijpharm.2004.12.022; PMID: 15778046
   PubMed Web of Science ®Google Scholar
• Paul A, Cevc G, Bachhawat BK. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine 1998; 16:188 - 95; http://dx.doi.org/10.1016/S0264-410X(97)00185-0; PMID: 9607029
   PubMed Web of Science ®Google Scholar
• Geusens B, Van Gele M, Braat S, De Smedt SC, Stuart MCA, Prow TW, et al. Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin. Adv Funct Mater 2010; 20:4077 - 90; http://dx.doi.org/10.1002/adfm.201000484
   Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. Eur J Pharm Sci 2008; 33:424 - 33; http://dx.doi.org/10.1016/j.ejps.2008.01.015; PMID: 18359615
   PubMed Web of Science ®Google Scholar
• Wang J, Hu JH, Li FQ, Liu GZ, Zhu QG, Liu JY, et al. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex. Exp Dermatol 2007; 16:724 - 9; http://dx.doi.org/10.1111/j.1600-0625.2007.00584.x; PMID: 17697144
   PubMed Web of Science ®Google Scholar
• Hansen S, Lehr C-M. Nanoparticles for transcutaneous vaccination. Microb Biotechnol 2012; 5:156 - 67; http://dx.doi.org/10.1111/j.1751-7915.2011.00284.x; PMID: 21854553
   PubMed Web of Science ®Google Scholar
• Romero EL, Morilla MJ. Topical and mucosal liposomes for vaccine delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3:356 - 75; http://dx.doi.org/10.1002/wnan.131; PMID: 21360692
   PubMed Web of Science ®Google Scholar
• Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006; 91:159 - 65; http://dx.doi.org/10.1093/toxsci/kfj122; PMID: 16443688
   PubMed Web of Science ®Google Scholar
• Patzelt A, Richter H, Knorr F, Schäfer U, Lehr CM, Dähne L, et al. Selective follicular targeting by modification of the particle sizes. J Control Release 2011; 150:45 - 8; http://dx.doi.org/10.1016/j.jconrel.2010.11.015; PMID: 21087645
   PubMed Web of Science ®Google Scholar
• Mittal A, Raber AS, Schaefer UF, Weissmann S, Ebensen T, Schulze K, et al. Non-invasive delivery of nanoparticles to hair follicles: A perspective for transcutaneous immunization. Vaccine 2013; In Press http://dx.doi.org/10.1016/j.vaccine.2012.12.048; PMID: 23290836
   PubMed Web of Science ®Google Scholar
• Jacobi U, Engel K, Patzelt A, Worm M, Sterry W, Lademann J. Penetration of pollen proteins into the skin. Skin Pharmacol Physiol 2007; 20:297 - 304; http://dx.doi.org/10.1159/000108101; PMID: 17851273
   PubMed Web of Science ®Google Scholar
• Fan H, Lin Q, Morrissey GR, Khavari PA. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999; 17:870 - 2; http://dx.doi.org/10.1038/12856; PMID: 10471927
   PubMed Web of Science ®Google Scholar
• Shaker DS, Sloat BR, Le UM, Löhr CV, Yanasarn N, Fischer KA, et al. Immunization by application of DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage. Mol Ther 2007; 15:2037 - 43; http://dx.doi.org/10.1038/sj.mt.6300286; PMID: 17700542
   PubMed Web of Science ®Google Scholar
• Baleeiro RB, Wiesmüller KH, Reiter Y, Baude B, Dähne L, Patzelt A, et al. Topical Vaccination with Functionalized Particles Targeting Dendritic Cells. J Invest Dermatol 2013; In Press http://dx.doi.org/10.1038/jid.2013.79; PMID: 23426134
   PubMed Web of Science ®Google Scholar
• Combadière B, Vogt A, Mahé B, Costagliola D, Hadam S, Bonduelle O, et al. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 2010; 5:e10818; http://dx.doi.org/10.1371/journal.pone.0010818; PMID: 20520820
   PubMed Web of Science ®Google Scholar
• Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, et al. The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol 2008; 65:488 - 92; http://dx.doi.org/10.1111/j.1365-2125.2007.03065.x; PMID: 18070215
   PubMed Web of Science ®Google Scholar
• Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007; 66:159 - 64; http://dx.doi.org/10.1016/j.ejpb.2006.10.019; PMID: 17169540
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Mechanical disruption of skin barrier for vaccine delivery. Drug Deliv Syst 2012; 27:202 - 12; http://dx.doi.org/10.2745/dds.27.202
   Google Scholar
• Lopez RF, Seto JE, Blankschtein D, Langer R. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials 2011; 32:933 - 41; http://dx.doi.org/10.1016/j.biomaterials.2010.09.060; PMID: 20971504
   PubMed Web of Science ®Google Scholar
• Karande P, Mitragotri S. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies. Annu Rev Chem Biomol Eng 2010; 1:175 - 201; http://dx.doi.org/10.1146/annurev-chembioeng-073009-100948; PMID: 22432578
   PubMed Web of Science ®Google Scholar
• Lisziewicz J, Rosenberg E, Lieberman J, Jessen H, Lopalco L, Siliciano R, et al. Control of HIV despite the discontinuation of antiretroviral therapy. [2] N Engl J Med 1999; 340:1683 - 4; http://dx.doi.org/10.1056/NEJM199905273402114; PMID: 10348681
   PubMed Web of Science ®Google Scholar
• Gudmundsdotter L, Wahren B, Haller BK, Boberg A, Edbäck U, Bernasconi D, et al. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial. Vaccine 2011; 29:5558 - 66; http://dx.doi.org/10.1016/j.vaccine.2011.01.064; PMID: 21300092
   PubMed Web of Science ®Google Scholar
• Lisziewicz J, Bakare N, Calarota SA, Bánhegyi D, Szlávik J, Újhelyi E, et al. Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals. PLoS One 2012; 7:e35416; http://dx.doi.org/10.1371/journal.pone.0035416; PMID: 22590502
   PubMed Web of Science ®Google Scholar
• Williams J, Fox-Leyva L, Christensen C, Fisher D, Schlicting E, Snowball M, et al. Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 2000; 18:1939 - 43; http://dx.doi.org/10.1016/S0264-410X(99)00446-6; PMID: 10699344
   PubMed Web of Science ®Google Scholar
• Matheï C, Van Damme P, Meheus A. Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle. Vaccine 1997; 15:402 - 4; http://dx.doi.org/10.1016/S0264-410X(96)00196-X; PMID: 9141211
   PubMed Web of Science ®Google Scholar
• Millar JD, Morris L, Macedo Filho A, Mack TM, Dyal W, Medeiros AA. The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil. Trop Geogr Med 1971; 23:89 - 101; PMID: 5573585
   PubMedGoogle Scholar
• Abb J, Deinhardt F, Eisenburg J. The risk of transmission of hepatitis B virus using jet injection in inoculation. J Infect Dis 1981; 144:179; http://dx.doi.org/10.1093/infdis/144.2.179; PMID: 7276631
   PubMed Web of Science ®Google Scholar
• Demuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater 2013; 23:161 - 72; http://dx.doi.org/10.1002/adfm.201201512; PMID: 23503923
   PubMed Web of Science ®Google Scholar
• Singh M, Chakrapani A, O’Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines 2007; 6:797 - 808; http://dx.doi.org/10.1586/14760584.6.5.797; PMID: 17931159
   PubMed Web of Science ®Google Scholar
• Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol Pharm 2007; 4:73 - 84; http://dx.doi.org/10.1021/mp060096p; PMID: 17274665
   PubMed Web of Science ®Google Scholar
• Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Hackbarth S, et al. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano 2012; 6:6829 - 42; http://dx.doi.org/10.1021/nn301622h; PMID: 22797484
   PubMed Web of Science ®Google Scholar
• Ma YF, Zhuang Y, Xie XF, Wang C, Wang F, Zhou DM, et al. The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Nanoscale 2011; 3:2307 - 14; http://dx.doi.org/10.1039/c1nr10166h; PMID: 21499635
   PubMed Web of Science ®Google Scholar
• Higa LH, Schilrreff P, Perez AP, Iriarte MA, Roncaglia DI, Morilla MJ, et al. Ultradeformable archaeosomes as new topical adjuvants. Nanomedicine 2012; 8:1319 - 28; http://dx.doi.org/10.1016/j.nano.2012.02.008; PMID: 22366598
   PubMed Web of Science ®Google Scholar
• Uto T, Akagi T, Hamasaki T, Akashi M, Baba M. Modulation of innate and adaptive immunity by biodegradable nanoparticles. Immunol Lett 2009; 125:46 - 52; http://dx.doi.org/10.1016/j.imlet.2009.05.008; PMID: 19505507
   PubMed Web of Science ®Google Scholar
• Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008; 371:2019 - 25; http://dx.doi.org/10.1016/S0140-6736(08)60839-9; PMID: 18554712
   PubMed Web of Science ®Google Scholar
• Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, Ben-Efraim S, Gupta CK. Adjuvants--a balance between toxicity and adjuvanticity. Vaccine 1993; 11:293 - 306; http://dx.doi.org/10.1016/0264-410X(93)90190-9; PMID: 8447157
   PubMed Web of Science ®Google Scholar
• Diwan M, Elamanchili P, Cao M, Samuel J. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr Drug Deliv 2004; 1:405 - 12; http://dx.doi.org/10.2174/1567201043334597; PMID: 16305402
   PubMedGoogle Scholar
• Wilson KD, de Jong SD, Tam YK. Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy. Adv Drug Deliv Rev 2009; 61:233 - 42; http://dx.doi.org/10.1016/j.addr.2008.12.014; PMID: 19232375
   PubMed Web of Science ®Google Scholar
• Bershteyn A, Hanson MC, Crespo MP, Moon JJ, Li AV, Suh H, et al. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J Control Release 2012; 157:354 - 65; http://dx.doi.org/10.1016/j.jconrel.2011.07.029; PMID: 21820024
   PubMed Web of Science ®Google Scholar
• Fischer S, Schlosser E, Mueller M, Csaba N, Merkle HP, Groettrup M, et al. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target 2009; 17:652 - 61; http://dx.doi.org/10.1080/10611860903119656; PMID: 19622019
   PubMed Web of Science ®Google Scholar
• Schlosser E, Mueller M, Fischer S, Basta S, Busch DH, Gander B, et al. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 2008; 26:1626 - 37; http://dx.doi.org/10.1016/j.vaccine.2008.01.030; PMID: 18295941
   PubMed Web of Science ®Google Scholar
• Bal SM, Hortensius S, Ding Z, Jiskoot W, Bouwstra JA. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination. Vaccine 2011; 29:1045 - 52; http://dx.doi.org/10.1016/j.vaccine.2010.11.061; PMID: 21129393
   PubMed Web of Science ®Google Scholar